Murine CMV Pneumonitis in Allogeneic BMT

  • Oakley, Oliver (PI)

Grants and Contracts Details


Despite the practice of antimicrobial prophylaxis, Cytomegalovirus (CMV) infection in immunocompromised patients causes potentially life-threatening disease, especially in recipients of bone marrow transplantation (BMT). CMV-associated pneumonitis is frequently a fatal complication of human CMV (hCMV) disease in BMT recipients. We will study an allogeneic murine BMT model in which BALB/c mice previously infected with murine CMV (MCMV) receive bone marrow from BI 0.02 donors. Previous studies have demonstrated hat animals previously infected with MCMV exhibit a more severe disease progression following ransplantation. To test our hypothesis: The mechanism by which reactivation oflatent MCMV infection exacerbates pneumonitis after minor antigen mismatched bone marrow transplantation is through 'augmentation of T cell infiltration and cytoldne production we have developed three specific aims. IThe specific aims to be addressed are I) To determine the role of viral replication on the development of IP after allo BMT, 2) To define the role of continued infiltration of T cells into the lungs of previously infected mice in the absence of replicating virus and 3) To determine the role of adhesion molecules in the development of viral interstitial pneumonitis following allo BMT. Using this model we will investigate the lrole viral replication following reactivation on disease progression. We will examine the specificity of lymphocytes in the lungs using MCMV specific MHC 11tetramers and Vj33. Also we will investigate the role of viral or host up-regulation of adhesion molecules in recruiting lymphocytes to the lungs. These experiments will provide insights into the interaction of host responses to CMV following BMT and may serve as a basis for developing new strategies to protect and treat BMT patients susceptible to chronic CMV infections. This research will also provide the opportunity for students to participate actively in the solution to an important clinical problem.
Effective start/end date8/15/058/31/08


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.